All In MedTech

FDA Clearance Tracker · P190022-S003

4Kscore Test

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Jul 25, 2025 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Jul 25, 2025

Approved

Time to decision

178 days

Received Jan 28, 2025. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P190022-S003
Device name
4Kscore Test
Applicant location
Miami, FL
Received
Jan 28, 2025
Decided
Jul 25, 2025
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P190022

Device type

Device class
Class III

Every decision under product code QRF

FDA's approval statement

As written in FDA's record.

Approval for the addition of the DRE Unavailable variant as part of the 4KScore Test system

Source documents

Other decisions for Opko Health, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.